We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Bausch & Lomb Seeks FDA Approval for Glaucoma Treatment
Bausch & Lomb Seeks FDA Approval for Glaucoma Treatment
Bausch & Lomb and Nicox are calling their once-daily eye drop for treating both open angle glaucoma and ocular hypertension a milestone in research and development in a medical area that has seen few new treatments in recent years.